For breast cancer, the cancer conventionally associated with Hunk, 1 out of 27 analyses (3.7%) within the Oncomine database demonstrate greater than 1.5 fold over-expression of Hunk (p < 0.01). Here, HUNK is linked to breast carcinoma.